Of all the federal government's science agencies, the National Institutes of Health looks to benefit most from the economic stimulus bill currently making its way through Congress. But how should the NIH spend the influx of cash that might be coming its way? linkurl:Steven Wiley,;http://www.sysbio.org/resources/staff/wiley.stm director of the Biomolecular Systems Initiative at Pacific Northwest National Laboratory, told __The Scientist__ that the NIH must increase its grant payline, which has hovered at a dismal 10% for the past few years. "There are wonderful grants out there that are just not being funded. The way the paylines are now is just killing people," said Wiley, who also serves on the editorial board of __The Scientist__. "I think that the best thing to do is to fund a greater percentage of the grants in the pipeline. This new money should get us back to where we should have been in the first place."...
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!